Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by KPOIndustrieson Sep 09, 2019 9:09am
148 Views
Post# 30107980

RE:RE:RE:Order ColonSentry for $375

RE:RE:RE:Order ColonSentry for $375 Well said!

wildbird1 wrote: The Snow Ball Effect !!!...

In the 2019 AGM at the 16.50 min time J.Tripp Said (Quote)" First of all if you go to a HealthPlan and show them that you can save them 1-2 % a year , you get there attention, when you show them double digit saving(over 10%), you absolutely get their attention"
 
At the 22.22 min time J.Tripp goes on to say " As an exemple, if they don't use SZLS they spend $900 million, if they use SZLS they spend $700 million , that is huge, this is a $200 million saving on $900 million" (End of Quote).

I am going to say something that may sound crude but Management (in Big Insurance Network and Big HealthPlan) main goal is not to save lives but to save money.

To resume, SZLS will not need like Exas:US to spend $10 million a year to promote their cancer tests.
Saving money is the biggest sale pitch of all, once SZLS has signed the first Big HealthCare System, other will be rushing to sign on just to save money.
Big Insurance network & Big HealthCare System will be the one that will be promoting SZLS tests to their patients (just to save money).

That is what you call the Snow Ball Effect.


Nolo wrote: That's great. Now they will need to spend some money to make that site and the company name known somehow. Otherwise, their only customers are gonna be... us. 




Bullboard Posts